ROLE OF DENDRITIC CELLS IN REGULATING VACCINE- INDUCED IMMUNITY AGAINST Q FEVER
树突状细胞在调节疫苗诱导的 Q 热免疫中的作用
基本信息
- 批准号:10049108
- 负责人:
- 金额:$ 12.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-05-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAerosolsAnimalsAntigen-Presenting CellsBone MarrowCD4 Positive T LymphocytesCell Differentiation processCell MaintenanceCell MaturationCellsCellular ImmunityChronicChronic DiseaseCoculture TechniquesCoxiella burnetiiDataDendritic CellsDevelopmentDiseaseEnzyme-Linked Immunosorbent AssayFlow CytometryFormalinFrequenciesGenerationsGoalsGram-Negative BacteriaHealthHumanImmuneImmune responseImmunityImmunizeIndividualInfectionInterleukin-12LipopolysaccharidesMHC Class II GenesMajor Histocompatibility ComplexMeasurableMeasuresMediatingMusOrganismOutcomes ResearchPatternPeptidesPhasePlayPreventionProductionQ FeverRiskRoleT cell differentiationT cell responseT-LymphocyteT-Lymphocyte SubsetsTestingTransgenic MiceVaccinationVaccine ProductionVaccinesVariantVirulentZoonosescytokinedesignfluin vivomouse modelnovelpathogenic microbeside effectvaccine-induced immunity
项目摘要
Abstract
Coxiella burnetii is an obligate intracellular Gram-negative bacterium that causes acute and chronic Q fever in
humans. There is an urgent need to create a safe and effective vaccine for prevention of human Q fever.
However, the mechanisms of vaccine-induced immunity against C. burnetii natural infection remain unclear.
The long-term goal of this project is to develop a safe and effective vaccine against Q fever. The objective of
this application, which is a critical step towards this goal, is to understand the role of dendritic cells (DCs) in
regulating vaccine-induced immunity against Q fever and identify which type of T cell response is more critical
for vaccine-induced protective immunity. To achieve this objective, two specific aims were proposed to test the
central hypothesis that C. burnetii phase I vaccine (PIV) and phase II vaccine (PIIV) differentially activate
DCs, thereby promoting distinct T cell responses are responsible for the difference in their ability to confer
protection. Aim 1 will determine the role of DCs in regulating vaccine-induced immunity against Q fever by
examining i) if PIV and PIIV differentially activate DCs, thereby promoting distinct T cell differentiation patterns
in a mouse model; and ii) if DCs play a role in vaccine-induced protection against C. burnetii aerosol infection
in vivo. Aim 2 will determine the role of CD4+ T cell subsets in PIV-induced protective immunity against C.
burnetii aerosol infection by using a mouse model to investigate i) if PIV- and PIIV-induced T cell responses
are responsible for the difference in their ability to confer protection; and ii) which CD4+ subset T cell response
is more critical for PIV-induced protection. As an outcome of this research, it will gain novel information for
understanding the role of DCs in regulating T cell-mediated immunity and determining the role of T cell
responses in vaccine-induced protective immunity against C. burnetii infection. This is expected to have
significant positive effects on publich health, because it will provide critical information for developing a safe
and effective vaccine against Q fever.
抽象的
伯纳特柯克斯体是一种专性细胞内革兰氏阴性细菌,可引起急性和慢性 Q 热
人类。迫切需要研制一种安全有效的疫苗来预防人类Q热。
然而,疫苗诱导的针对伯氏念珠菌自然感染的免疫机制仍不清楚。
该项目的长期目标是开发一种安全有效的 Q 热疫苗。的目标
该应用是实现这一目标的关键一步,旨在了解树突状细胞 (DC) 在
调节疫苗诱导的 Q 热免疫并确定哪种类型的 T 细胞反应更为关键
用于疫苗诱导的保护性免疫。为了实现这一目标,提出了两个具体目标来测试
中心假设:伯内特衣原体 I 期疫苗 (PIV) 和 II 期疫苗 (PIIV) 的激活差异
DC 从而促进不同的 T 细胞反应,这导致了它们赋予能力的差异。
保护。目标 1 将通过以下方式确定 DC 在调节疫苗诱导的 Q 热免疫中的作用:
检查 i) PIV 和 PIIV 是否差异性激活 DC,从而促进不同的 T 细胞分化模式
在小鼠模型中; ii) DC 是否在疫苗诱导的伯内特衣原体气溶胶感染保护中发挥作用
体内。目标 2 将确定 CD4+ T 细胞亚群在 PIV 诱导的针对念珠菌的保护性免疫中的作用。
使用小鼠模型研究伯内氏气溶胶感染 i) PIV 和 PIIV 是否诱导 T 细胞反应
对他们提供保护的能力的差异负责; ii) 哪种 CD4+ 亚群 T 细胞反应
对于 PIV 诱导的保护更为重要。作为这项研究的成果,它将获得新的信息
了解 DC 在调节 T 细胞介导的免疫中的作用并确定 T 细胞的作用
疫苗诱导的针对伯内特念珠菌感染的保护性免疫反应。预计这将有
对公共卫生产生重大积极影响,因为它将为制定安全的方法提供关键信息
以及针对 Q 热的有效疫苗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guoquan Zhang其他文献
Guoquan Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guoquan Zhang', 18)}}的其他基金
Mechanisms of B-1 Cell-Mediated Immunity Against Coxiella burnetii Infection
B-1细胞介导的伯氏柯克斯体感染免疫机制
- 批准号:
10155409 - 财政年份:2020
- 资助金额:
$ 12.48万 - 项目类别:
IDENTIFY NOVEL NEUTRALIZATION-SENSITIVE EPITOPES OF COXIELLA BURNETII
鉴定伯内特丘克斯体的新型中和敏感表位
- 批准号:
10020119 - 财政年份:2019
- 资助金额:
$ 12.48万 - 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
- 批准号:
10207396 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
- 批准号:
10005679 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Use of a Humanized Antibody against Intracellular Bacterial Pathogen
抗细胞内细菌病原体的人源化抗体的用途
- 批准号:
10003580 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
- 批准号:
9982219 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Mimetic Peptides-Mediated Protection Against Coxiella burnetii Infection
模拟肽介导的伯氏柯克斯体感染保护
- 批准号:
9762833 - 财政年份:2018
- 资助金额:
$ 12.48万 - 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
- 批准号:
8582500 - 财政年份:2010
- 资助金额:
$ 12.48万 - 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
- 批准号:
8386914 - 财政年份:2010
- 资助金额:
$ 12.48万 - 项目类别:
Development of O Antigen-based Vaccines Against Q Fever
基于 O 抗原的 Q 热疫苗的开发
- 批准号:
8197349 - 财政年份:2010
- 资助金额:
$ 12.48万 - 项目类别:
相似国自然基金
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高分辨率气溶胶特性的卫星遥感探测机理与算法模型研究
- 批准号:42375129
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
西北不同生态系统下气溶胶对边界层辐射平衡的影响及模拟研究
- 批准号:42375085
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
污染环境下多尺度气溶胶粒子散射特性研究
- 批准号:52376072
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
二次有机气溶胶理化性质对其冰核性能的影响
- 批准号:42375069
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Project 1: Translational Studies on Temperature and Solvent Effects on Electronic Cigarette-Derived Oxidants
项目1:温度和溶剂对电子烟氧化剂影响的转化研究
- 批准号:
10665896 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
Diversity Supplement to Microvascular mechanisms of growth restriction after environmental toxicant exposure (R01ES031285)
环境毒物暴露后生长受限的微血管机制的多样性补充(R01ES031285)
- 批准号:
10849145 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
Long-acting aldicarb hydrolase as a medical countermeasure for aldicarb poisoning
长效涕灭威水解酶作为涕灭威中毒的医学对策
- 批准号:
10724752 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
The impact of a neonicotinoid pesticide on neural functions underlying learning and memory
新烟碱类农药对学习和记忆神经功能的影响
- 批准号:
10646631 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别:
Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
- 批准号:
10658610 - 财政年份:2023
- 资助金额:
$ 12.48万 - 项目类别: